mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
Salubrinal |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.1 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.1 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
-0.048 |
0.1 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.1 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |